Pancreatic Cancer Trial, Recruiting (NCT06144762)

Pancreatic Cancer Trial, Recruiting NCT06144762 Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle Condition: Pancreatic Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06144762 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Pancreatic Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You must be 18 years of age or older
You have been diagnosed with pancreatic cancer that has been confirmed through a tissue or cell sample (biopsy), and your doctors have planned for you to have surgery either straight away or after chemotherapy treatment first
Women who could become pregnant must have a negative pregnancy test before joining
You must be covered by a health insurance or social protection system
You must be willing to sign a consent form agreeing to take part before the trial begins

Who may not be able to join:

Your cancer has spread to other parts of the body (metastases)
Surgery is not part of your planned treatment
You are currently pregnant or breastfeeding
You have a mental, psychological, physical, or legal condition that would make it difficult or impossible for you to take part in the trial (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 14 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: NOUGARET Stephanie, INSTITUT REGIONAL DU CANCER DE MONTPELLIER Cancer de Montpellier

Phone: 0467613102

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06144762

Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle

Phase: Not Applicable

Status: Recruiting

Condition: Pancreatic Cancer

Trial contact: 0467613102

More information: https://clinicaltrials.gov/study/NCT06144762

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You must be 18 years of age or older
You have been diagnosed with pancreatic cancer that has been confirmed through a tissue or cell sample (biopsy), and your doctors have planned for you to have surgery either straight away or after chemotherapy treatment first
Women who could become pregnant must have a negative pregnancy test before joining
You must be covered by a health insurance or social protection system
You must be willing to sign a consent form agreeing to take part before the trial begins

Who may not be able to join:

Your cancer has spread to other parts of the body (metastases)
Surgery is not part of your planned treatment
You are currently pregnant or breastfeeding
You have a mental, psychological, physical, or legal condition that would make it difficult or impossible for you to take part in the trial (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 14 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Institut du Cancer de Montpellier - Val d'Aurelle

Registry

ClinicalTrials.gov

Start date

19 December 2023

Est. completion

1 October 2029

Where this trial is recruiting

🇫🇷 France

Primary endpoints

the integration of in vivo and ex vivo MRI with histology and molecular caracteristic in order to increase the pancreatic cancer detection and therapeutic response monitoring

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov